Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)

Insight Molecular Diagnostics (IMDX) has disclosed Return on Invested Capital for 3 consecutive years, with 2.56% as the latest value for Q3 2024.

  • Quarterly Return on Invested Capital changed N/A to 2.56% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 2.56% through Sep 2024, changed N/A year-over-year, with the annual reading at 0.33% for FY2022, 53.0% up from the prior year.
  • Return on Invested Capital hit 2.56% in Q3 2024 for Insight Molecular Diagnostics, down from 2.1% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.25% in Q2 2021 to a low of 2.56% in Q3 2024.
  • Historically, Return on Invested Capital has averaged 1.17% across 3 years, with a median of 0.78% in 2020.
  • Biggest YoY gain for Return on Invested Capital was 3bps in 2021; the steepest drop was 3bps in 2021.
  • Year by year, Return on Invested Capital stood at 0.79% in 2020, then increased by 3bps to 0.77% in 2021, then plummeted by -234bps to 2.56% in 2024.
  • Business Quant data shows Return on Invested Capital for IMDX at 2.56% in Q3 2024, 2.1% in Q2 2024, and 2.23% in Q1 2024.